Clinical Trial Update: A Study of Ustekinumab (STELARA®) in Adult Japanese Participants With Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating ustekinumab (Stelara) in adult Japanese participants with severe atopic dermatitis; the trial has completed and results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Stelara (ustekinumab)

Snippet

Sponsor: Janssen Pharmaceutical K.K. | Conditions: Dermatitis, Atopic | Phase 2 | Status: COMPLETED | Results posted: 2016-03-09